Ad
Ad
Ad
© qualcomm Electronics Production | April 17, 2017

'Dr. McCoy. Report to sickbay immediately!'

Final Frontier Medical Devices and Dynamical Biomarkers Group developed the first proper, modern-day tricorder, otherwise known as the medical 'Wunderwaffe' of the Star Trek universe.
Or as the Qualcomm Tricorder XPRIZE has it: "the first consumer-focused, mobile diagnostic device inspired by the medical tricorder of Star Trek". We, here at Evertiq, generally do not report on awards, prizes and such, but the Tricorder challenge and the final prototypes had us interested.

Final Frontier Medical Devices (received USD 2.5M) and Dynamical Biomarkers Group (received USD 1M) both nearly met the challenging audacious benchmarks for diagnosing the 13 disease states, a press release states.

After four years of development, team Final Frontier created DxtER (pronounced “Dexter”), an artificial intelligence-based engine that learns to diagnose medical conditions by integrating learnings from clinical emergency medicine with data analysis from actual patients. DxtER includes a group of non-invasive sensors that are designed to collect data about vital signs, body chemistry and biological functions. This information is then synthesized in the device’s diagnostic engine to make a quick and accurate assessment.

“It is very exciting that our vision of mobile, personalized patient-centric healthcare is getting closer to becoming a reality thanks to the great work of the Qualcomm Tricorder XPRIZE teams,” said Dr. Paul E. Jacobs, executive chairman of Qualcomm Incorporated. “Creating technology breakthroughs in an industry as complex as healthcare is quite a milestone, and what these teams accomplished is a great stepping stone to making mobile healthcare a viable option across the world.”

Comments

Please note the following: Critical comments are allowed and even encouraged. Discussions are welcome. Verbal abuse, insults and racist / homophobic remarks are not. Such comments will be removed.
Further details can be found here.
Ad
Ad
Load more news
June 25 2017 8:55 PM V8.5.5-1